Health and Healthcare
GlaxoSmithKline Continues Down A Dangerous Path
Published:
Two more studies show that GlaxoSmithKline (GSK) blockbuster diabetes drug Avandia has significant health risks.
According to The Wall Street Journal "the Food and Drug Administration is considering whether Avandia’s use should be restricted." Studies show that the drug can increase risk of heart attack. In a research paper form Wake Forest University doctors found that patients taking Avandia had a 42% greater chance of having a heart attack than those in the control group.
The whole incident begs that question of what major drug companies never take their own products off the market when there is overwhelming evidence that they create health risk. There must be some actuary who works out the balance between profit and potential liability if court cases for wrongful death begin to emerge.
Of course, that leaves out the question of ethics.
Douglas A. McIntyre
Essential Tips for Investing: Sponsored
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
